Michael Kalfas

PhD Student @ImperialMed

[FC Barcelona @FCBarcelona_cat]

La trobada somiada del futbol mundial que ja va anticipar la @FundacioFCB 😍

La història darrere d'aquesta foto 👉 https://t.co/iJQGriFsP5

📸 Joan Monfort (Diari Sport)

[KCL CfAD @kclcfad]

We're back.

The Centre for Affective Disorders at KCL is one of the UK's leading centres for research into depression, anxiety and related conditions, with a focus on improving treatments and patient outcomes.

Follow us for updates on research, studies and events.

[FC Barcelona @FCBarcelona_cat]

T'estimem, Hansi! 🫶

[FC Barcelona @FCBarcelona_cat]

𝗖𝗔𝗠𝗣𝗜𝗢𝗡𝗦 🏆
No és només una Lliga.
És història. 💙❤️

[FC Barcelona @FCBarcelona_cat]

LA SUPERCOPA ÉS BLAUGRANA.

[Milwaukee Bucks @Bucks]

How it started vs. how it's going.

(via kostas__ante37/IG)

[FIBA EuroBasket @EuroBasket]

"I don't like being famous, I just like basketball."

Giannis with a GOAT post-game speech. 🥹❤️

#EuroBasket | #MakeYourMark

[JAMA Psychiatry @JAMAPsych]

Most viewed this week from @JAMAPsych:

Systematic review and meta-analysis: Stopping antidepressants leads to slight symptom increases compared to placebo, but these symptoms are not clinically significant and do not include mood changes.

https://t.co/s5UGc7qKIJ

[Science Media Centre UK @SMC_London]

expert reaction to systematic review and meta-analysis on antidepressant withdrawal symptoms
https://t.co/JcTfNeRRiF

[Imperial College London @imperialcollege]

Antidepressant withdrawal symptoms may be less common than previously thought, a 'gold standard' data review has found.

@ImperialBrains, @KingsCollegeLon and @UCL researchers reviewed 50 studies with more than 17,000 participants 🔽

https://t.co/E8aLQgEqpS

[Institute of Psychiatry, Psychology & Neuroscience @KingsIoPPN]

The largest review of its kind on #antidepressant withdrawal symptoms published results yesterday.

Researchers say it provides much needed, clearer guidance for clinicians, patients and policymakers.

Click the link to read more👇

#IoPPNNews

https://t.co/MUhJDnJREr

[Dr Gemma Lewis @GemmaLewis13]

Our new review on antidepressant withdrawal led by @kalfas_michael @sameerjauhar

Estimates similar to ANTLER trial where ~75% had been on antidepressants for >3 years & were followed for 12 months

Variability around this estimate - 3% of people experience severe withdrawal

[Thomas Reilly @Rational_Psych]

Congratulations @sameerjauhar et al

I look forward to finally reading this paper I’ve heard so much about but sorry it has led to such vitriol and abuse on here 😔

[Michael Kalfas @kalfas_michael]

Our new meta-analysis exploring the incidence and nature of antidepressant discontinuation symptoms, published in JAMA Psychiatry

[JAMA Psychiatry @JAMAPsych]

Systematic review and meta-analysis: Stopping antidepressants leads to slight symptom increases compared to placebo, but these symptoms are not clinically significant and do not include mood changes. https://t.co/zxtZH34uRu

[Tony Cleare @TCleare]

Published today in Lancet Psychiatry, after 7 years of hard labour... the first long-term head-to-head comparison of two augmentation treatments in treatment resistant depression. Clinical and cost-effectiveness of lithium versus quetiapine augmentat... https://t.co/tF5qUcTkzl

[Reshad Rahman @ReshadRahman]

AURA.

[The Mental Elf @Mental_Elf]

Jury remains out on antidepressant-induced mania, despite findings of Danish trial emulation https://t.co/xHL7X9m8lI

Michael Kalfas and Paul Leeks summarise a recent Danish study that assesses the risk of antidepressant-induced mania in patients with bipolar depression.

[KCL CfAD @kclcfad]

@kclcfad CRiB2 researchers @kalfas_michael and @Rosie_H_Taylor presented preliminary findings regarding the discrepancy between subjective and objective reports of cognitive performance at #ISAD2023

The implications for cognitive remediation therapy were discussed

[KCL CfAD @kclcfad]

Anna Tröger (a @kclcfad PhD student) presents her poster, a meta-analysis and meta-regression reporting that:
Baseline depression severity does not moderate the effects of psychotherapy compared with pharmacotherapy for depression.

#ISAD2023